Cargando…

Hepatitis C virus infection suppresses hepatitis B virus replication via the RIG-I-like helicase pathway

Mechanisms of hepatitis B virus (HBV) reactivation after hepatitis C virus (HCV) elimination by direct-acting antiviral (DAA) treatment in HBV/HCV-co-infected patients remain unclear. We examined RIG-I-like helicase (RLH) pathway activation by HBV mono-infection, HCV mono-infection or HBV/HCV co-inf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murai, Kazuhiro, Hikita, Hayato, Kai, Yugo, Kondo, Yasuteru, Fukuoka, Makoto, Fukutomi, Keisuke, Doi, Akira, Yamai, Takuo, Nakabori, Tasuku, Fukuda, Ryo, Takahashi, Takeshi, Miyakawa, Kei, Suemizu, Hiroshi, Ryo, Akihide, Yamada, Ryoko, Kodama, Takahiro, Sakamori, Ryotaro, Tatsumi, Tomohide, Takehara, Tetsuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6976581/ https://www.ncbi.nlm.nih.gov/pubmed/31969598 http://dx.doi.org/10.1038/s41598-020-57603-9

Ejemplares similares

Capsid Allosteric Modulators Enhance the Innate Immune Response in Hepatitis B Virus–Infected Hepatocytes During Interferon Administration
por: Fukutomi, Keisuke, et al.
Publicado: (2021)

Sodium taurocholate cotransporting polypeptide inhibition efficiently blocks hepatitis B virus spread in mice with a humanized liver
por: Nakabori, Tasuku, et al.
Publicado: (2016)

Baseline quasispecies selection and novel mutations contribute to emerging resistance-associated substitutions in hepatitis C virus after direct-acting antiviral treatment
por: Kai, Yugo, et al.
Publicado: (2017)

The Hepatitis B Virus Genotype Affects the Persistence of Viral Replication in Immunodeficient NOG Mice
por: Yokoyama, Yoshinobu, et al.
Publicado: (2015)

Hepatitis C virus enhances Rubicon expression, leading to autophagy inhibition and intracellular innate immune activation
por: Shiode, Yuto, et al.
Publicado: (2020)

Inhibition of nonhomologous end joining‐mediated DNA repair enhances anti‐HBV CRISPR therapy
por: Murai, Kazuhiro, et al.
Publicado: (2022)

Improvement of Skeletal Muscle Mass after Ledipasvir and Sofosbuvir Treatment for Hepatitis C Virus in Decompensated Liver Cirrhosis
por: Sakamori, Ryotaro, et al.
Publicado: (2021)

Feasibility of immunotherapy in cancer patients with persistent or past hepatitis B or C virus infection
por: Nakabori, Tasuku, et al.
Publicado: (2022)

Frequency and role of NKp46 and NKG2A in hepatitis B virus infection
por: Yoshioka, Teppei, et al.
Publicado: (2017)

Pre-existing minor variants with NS5A L31M/V-Y93H double substitution are closely linked to virologic failure with asunaprevir plus daclatasvir treatment for genotype 1b hepatitis C virus infection
por: Morishita, Naoki, et al.
Publicado: (2020)

Hyperglycemia enhances pancreatic cancer progression accompanied by elevations in phosphorylated STAT3 and MYC levels
por: Sato, Katsuhiko, et al.
Publicado: (2020)

Fucosylated haptoglobin is a novel predictive marker of hepatocellular carcinoma after hepatitis C virus elimination in patients with advanced liver fibrosis
por: Shirai, Kumiko, et al.
Publicado: (2022)

CEACAM1 Is Associated With the Suppression of Natural Killer Cell Function in Patients With Chronic Hepatitis C
por: Suda, Takahiro, et al.
Publicado: (2018)

Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C
por: Tawara, Seiichi, et al.
Publicado: (2016)

Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral
por: Matsumae, Takayuki, et al.
Publicado: (2023)

CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular Carcinoma
por: Suemura, Shigeki, et al.
Publicado: (2019)

Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patients
por: Shirai, Kumiko, et al.
Publicado: (2022)

TNF receptor–related factor 3 inactivation promotes the development of intrahepatic cholangiocarcinoma through NF‐κB‐inducing kinase–mediated hepatocyte transdifferentiation
por: Shiode, Yuto, et al.
Publicado: (2023)

The First Case of Coil Embolization for Left Gastric Vein Aneurysm with Liver Cirrhosis: A Case Report and Review of the Literature
por: Kato, Seiya, et al.
Publicado: (2021)

Increased Bcl-xL Expression in Pancreatic Neoplasia Promotes Carcinogenesis by Inhibiting Senescence and Apoptosis
por: Ikezawa, Kenji, et al.
Publicado: (2017)

Hepatocellular Carcinoma in a Patient with Tetralogy of Fallot: A Case Report and Literature Review
por: Hyun Sung, Ji, et al.
Publicado: (2021)

Liver Fibrosis Is Associated With Corrected QT Prolongation During Ledipasvir/Sofosbuvir Treatment for Patients With Chronic Hepatitis C
por: Tahata, Yuki, et al.
Publicado: (2018)

Hepatitis C Virus Evasion from RIG-I-Dependent Hepatic Innate Immunity
por: Liu, Helene Minyi, et al.
Publicado: (2010)

A case of refractory tumor bleeding from an ampullary adenocarcinoma: Compression hemostasis with a self‐expandable metallic stent
por: Daiku, Kazuma, et al.
Publicado: (2021)

Prolyl Isomerase Pin1 Regulates the Stability of Hepatitis B Virus Core Protein
por: Nishi, Mayuko, et al.
Publicado: (2020)

Transcriptomics Identify Thrombospondin‐2 as a Biomarker for NASH and Advanced Liver Fibrosis
por: Kozumi, Kazuhiro, et al.
Publicado: (2021)

Constitutive Activation of the Tumor Suppressor p53 in Hepatocytes Paradoxically Promotes Non–Cell Autonomous Liver Carcinogenesis
por: Makino, Yuki, et al.
Publicado: (2022)

Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination Immunotherapy
por: Matsumae, Takayuki, et al.
Publicado: (2022)

Engineering Cellular Biosensors with Customizable Antiviral Responses Targeting Hepatitis B Virus
por: Matsunaga, Satoko, et al.
Publicado: (2020)

Hepatitis B virus rigs the cellular metabolome to avoid innate immune recognition
por: Zhou, Li, et al.
Publicado: (2021)

Generation and Utilization of a Monoclonal Antibody against Hepatitis B Virus Core Protein for a Comprehensive Interactome Analysis
por: Nakai, Yusuke, et al.
Publicado: (2022)

Success rate of microsatellite instability examination and complete response with pembrolizumab in biliary tract cancer
por: Kai, Yugo, et al.
Publicado: (2021)

Persistent hepatocyte apoptosis promotes tumorigenesis from diethylnitrosamine-transformed hepatocytes through increased oxidative stress, independent of compensatory liver regeneration
por: Nozaki, Yasutoshi, et al.
Publicado: (2021)

Hepatitis E Virus ORF2 Inhibits RIG-I Mediated Interferon Response
por: Hingane, Smita, et al.
Publicado: (2020)

White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice
por: Sakane, Sadatsugu, et al.
Publicado: (2021)

Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells
por: Nie, Yun-Zhong, et al.
Publicado: (2018)

Hepatitis B virus inhibits intrinsic RIG-I and RIG-G immune signaling via inducing miR146a
por: Hou, Zhaohua, et al.
Publicado: (2016)

Primary Pancreatic Mantle Cell Lymphoma Diagnosed via Endoscopic Ultrasound-Guided Fine-Needle Aspiration
por: Yamai, Takuo, et al.
Publicado: (2021)

5-Fluorouracil/L-Leucovorin Plus Oxaliplatin (FOLFOX) Regimen as Salvage Chemotherapy for Patients with Unresectable Pancreatic Cancer Receiving Gemcitabine and Nab-Paclitaxel and 5-Fluorouracil/L-Leucovorin Plus Nanoliposomal Irinotecan: Preliminary Results from Clinical Practice
por: Yamai, Takuo, et al.
Publicado: (2022)

Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptide
por: Miyakawa, Kei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_js7v5cci2imvreh8p9huctf826